特朗普对中国药物的关税 可能会抬高价格 并导致美国和加拿大的短缺 Trump's tariffs on Chinese drugs may raise prices and cause shortages in the U.S. and Canada.

唐纳德·特朗普对中国药品提议的关税可能会提高加拿大和美国的药品价格,影响数百万人。 Donald Trump's proposed tariffs on Chinese pharmaceuticals could raise drug prices in Canada and the U.S., impacting millions. 在加拿大,55%的加拿大人依赖雇主赞助的药物计划,因此,关税造成的就业损失也可能意味着丧失健康福利。 In Canada, 55% of Canadians rely on employer-sponsored drug plans, so job losses from tariffs could also mean losing health benefits. 关税可能导致成本上升和短缺,影响基本药品的获得。 The tariffs could lead to higher costs and shortages, affecting access to essential medications. 作为回应,加拿大的《药物护理法》旨在确保所有加拿大人都能买得起必要的药物,尽管只有一些省份同意在该计划下涵盖特定药物。 In response, Canada's Pharmacare Act aims to ensure all Canadians can afford necessary drugs, though only some provinces have agreed to cover specific drugs under the plan.